GALT icon

Galectin Therapeutics
GALT

Overview Fund Trends Analyst Outlook Journalist POV

26 hedge funds and large institutions have $10.4M invested in Galectin Therapeutics in 2013 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $204K

Holders
26
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
$204K
Net Calls
Net Calls Change

Top Buyers

1
+$1.52M
2
+$728K
3
+$454K
4
Northern Trust
Northern Trust
Illinois
+$320K
5
LTFS
Ladenburg Thalmann Financial Services
Florida
+$191K

Top Sellers

1
-$767K
2
-$67.8K
3
-$1.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$1K
1
2